查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1771508

全球智慧治療設備市場：市場規模、佔有率、趨勢分析（按設備、分佈、最終用途和地區）、細分市場預測（2025-2030 年）

Smart Therapeutic Devices Market Size, Share & Trends Analysis Report By Devices, By Distribution (Pharmacies, Online Channel, Direct-to-Consumer (DTC)), By End Use (Hospitals, Clinics, Home Care), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

智慧醫療器材市場摘要

預計 2024 年全球智慧治療設備市場規模為 771.2 億美元，到 2030 年將達到 1,594.2 億美元，2025 年至 2030 年的複合年成長率為 12.99%。這一成長得益於技術進步、慢性病患病率上升以及個人化醫療和居家醫療需求的不斷成長。

這一成長得益於技術進步、慢性病患病率上升以及個性化居家照護需求的不斷成長。此外，攜帶式連網設備（例如胰島素幫浦、智慧吸入器和神經刺激系統）的普及率也不斷提高，這些設備顯著增強了疾病管理能力，尤其是在糖尿病、氣喘、慢性阻塞性肺病和神經系統疾病方面。人工智慧、數據追蹤和無線連接的整合實現了即時監測、患者參與和臨床決策，從而改善了治療效果並提高了患者依從性。

由於慢性病管理需要持續護理，智慧治療設備可以彌合門診和居家醫療之間的差距，最終有助於改善生活品質並降低住院率。例如，Omron Healthcare於2022年7月推出了可攜帶式氧氣設備，該設備採用PSA技術，以每分鐘5公升的速度輸送純度超過90%的氧氣。該設備專為家庭護理而設計，結構緊湊耐用，並配有腳輪，方便移動。

此外，個人化醫療趨勢持續加速智慧科技的普及。例如，2024年2月，Tandem Diabetes Care 推出了 Tandem Mobi，這是全球最小巧耐用的自動化胰島素輸送系統。這款緊湊型穿戴式裝置可透過 iOS 系統實現完全的行動控制，採用先進的 Control-IQ 技術，並與 Dexcom CGM 相容，為 6 歲及以上用戶提供個人化胰島素治療。

根據世界衛生組織（WHO）統計，截至2024年，包括心血管疾病、癌症、糖尿病和慢性呼吸系統疾病在內的非傳染性疾病（NCD）佔全球年度死亡人數的74%以上。為此，WHO正在積極推動增加對數位醫療解決方案（包括遠端醫療和行動醫療技術）的投資，以此作為管理和減少NCD影響的經濟有效的策略。特別是，預計未來十年，每位患者每年僅需在數位醫療干預方面投資0.24美元，就能挽救200多萬人的生命，並預防近700萬例急性疾病和住院治療，從而顯著緩解全球醫療體系的壓力。

當今世界的需求正推動醫療技術供應商擴展其智慧治療設備組合併使其更加多樣化。一個典型的例子是ReSound Vivia，它號稱是全球最小的人工智慧助聽器，由GN於2025年2月推出。這款助聽器經過1350萬個真實句子的訓練，顯著提高了嘈雜環境中的語音清晰度，同時提供長達30小時的持久電池續航時間，可滿足全天使用。 GN ReSound也推出了ReSound Savi，這是一個以價值主導的產品系列，具有藍牙LE音訊和Auracast廣播功能。

新冠疫情顯著增加了對可攜帶式氧氣設備和人工呼吸器等智慧型治療設備的需求，這些設備已成為管理呼吸系統併發症的關鍵。由於人們對呼吸系統疾病的認知不斷提高，智慧吸入器、連網吸入器和慢性阻塞性肺病 (COPD) 管理工具備受關注。同時，胰島素幫浦、穿戴式注射器和植入式給藥系統也有助於減少慢性疾病患者的就診次數。疫情也透過遠端醫療整合促進了神經刺激和助聽設備的普及。

目錄

第1章 分析方法與範圍

第2章執行摘要

第3章 市場促進因素、趨勢與範圍

  • 市場聯動展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制分析
    • 產業機會分析
    • 產業問題分析
    • 案例研究
  • 商業環境分析
    • 產業分析：波特五力分析
    • PESTEL分析
  • COVID-19影響分析

第4章智慧醫療設備市場：按醫療設備類型的估計和趨勢分析

  • 細分儀表板：按治療設備
  • 治療設備的市場佔有率及變化分析（2024 年及 2030 年）
  • 依治療設備類型分類的市場規模預測及趨勢分析（2018-2030年）
    • 可攜帶式氧氣設備和人工呼吸器
    • 胰島素幫浦
    • 助聽器
    • 神經刺激設備
    • 智慧吸入器
    • 智慧型藥物傳輸系統

第5章智慧治療設備市場：按分銷管道進行的估計和趨勢分析

  • 細分儀表板：依分佈
  • 各地區市場佔有率及變化分析（2024年及2030年）
  • 按分銷管道分類的市場規模預測和趨勢分析（2018-2030 年）
  • 藥局
    • 藥局市場（2018-2030）
  • 線上管道
    • 線上通路市場（2018-2030）
  • 直接面對消費者（DTC）
    • 直接面對消費者 (DTC) 市場（2018-2030 年）
  • 其他（大賣場、專業零售商）
    • 其他（大賣場、專業零售商）市場（2018-2030）

第6章：智慧治療設備市場：依最終用途的估計和趨勢分析

  • 細分儀表板：依最終用途
  • 按最終用途分類的市場佔有率及變化分析（2024 年及 2030 年）
  • 按最終用途分類的市場規模預測和趨勢分析（2018-2030 年）
  • 醫院
    • 醫院市場（2018-2030）
  • 診所
    • 診所市場（2018-2030）
  • 居家醫療
    • 居家醫療市場（2018-2030）
  • 其他（運動、健身中心、輔助生活設施）
    • 其他（運動、健身中心、輔助生活）市場（2018-2030）

第7章智慧型治療設備市場：按地區估計和趨勢分析

  • 市場儀表板：按地區
  • 區域市場：關鍵要點
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭態勢

  • 參與者概覽
  • 企業市場分析
  • 公司分類
  • 戰略地圖
  • 公司簡介/上市公司
    • Inogen, Inc.
    • Presspart Verwaltungs GmbH.
    • Cognita Labs
    • adherium
    • Medtronic
    • Hoffmann-La Roche AG
    • Insulet Corporation
    • Audicus
    • Eargo, Inc.
    • Nidek Medical Products, Inc.
    • Koninklijke Philips NV
    • Drive Devilbiss International
    • Tandem Diabetes Care, Inc.
    • Ypsomed
    • GN Hearing
    • Cochlear Ltd.
    • Sonova.
    • Boston Scientific Corporation
    • Abbott.
    • Nevro Corp.
Product Code: GVR-4-68040-606-7

Smart Therapeutic Devices Market Summary

The global smart therapeutic devices market size was estimated at USD 77.12 billion in 2024 and is projected to reach USD 159.42 billion by 2030, growing at a CAGR of 12.99% from 2025 to 2030. This growth is attributed to technological advancements, rising prevalence of chronic diseases, and the growing demand for personalized and home-based care.

This growth is attributed to technological advancements, rising prevalence of chronic diseases, and the growing demand for personalized and home-based care. Moreover, increasing adoption of portable and connected devices-such as insulin pumps, smart inhalers, and neurostimulation systems-has significantly enhanced disease management capabilities, particularly for conditions like diabetes, asthma, COPD, and neurological disorders. The integration of AI, data tracking, and wireless connectivity enables real-time monitoring, patient engagement, and clinical decision-making, thereby improving treatment outcomes and patient adherence.

With chronic disease management requiring continuous care, smart therapeutic devices bridge the gap between hospital visits and home-based healthcare, ultimately contributing to improved quality of life and reduced hospitalization rates. For instance, in July 2022, OMRON Healthcare launched a portable oxygen concentrator delivering 5L/min of >90% pure oxygen using PSA technology. Designed for home care, it features a compact, durable design with caster wheels for mobility.

Moreover, the trend toward personalized medicine continues to accelerate the adoption of smart technologies. For instance, in February 2024, Tandem Diabetes Care launched Tandem Mobi, the world's smallest durable automated insulin delivery system. This compact, wearable device offers full iOS mobile control, advanced Control-IQ technology, and compatibility with Dexcom CGMs, enabling personalized insulin therapy for users aged six and up.

According to the World Health Organization (WHO), as of 2024, noncommunicable diseases (NCDs) such as cardiovascular diseases, cancer, diabetes, and chronic respiratory conditions account for over 74% of global mortality annually. In response, the WHO is actively promoting greater investment in digital health solutions-including telemedicine and mobile health technologies-as a cost-effective strategy to manage and mitigate the impact of NCDs. Notably, an investment of merely USD 0.24 per patient per year in digital health interventions is projected to save over 2 million lives and prevent nearly 7 million acute events and hospitalizations over the next decade, thereby alleviating significant pressure on global healthcare systems.

These global imperatives are driving healthcare technology providers to expand and diversify their smart therapeutic device portfolios. A key example is GN's February 2025 launch of ReSound Vivia, touted as the world's smallest AI-powered hearing aid. Trained on 13.5 million real-world sentences, the device significantly enhances speech clarity in noisy environments while offering extended battery life of up to 30 hours for all-day use. GN also introduced ReSound Savi, a value-driven product line featuring Bluetooth LE Audio and Auracast broadcast capabilities-further democratizing access to advanced hearing solutions and aligning with global digital health priorities.

The COVID-19 pandemic significantly increased the demand for smart therapeutic devices like portable oxygen concentrators and ventilators became critical for managing respiratory complications. Smart inhalers, connected inhalers, and COPD management tools gained prominence due to the rise in respiratory illness awareness. On the other hand, insulin pumps, wearable injectors, and implantable drug delivery devices helped reduce hospital visits for chronic disease patients. The pandemic also pushed the adoption of neurostimulation and hearing devices through telehealth integration.

Global Smart Therapeutic Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global smart therapeutic devices market report based on devices, distribution, end use and regions.

  • Devices Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Portable Oxygen Concentrators & Ventilators
  • Insulin Pumps
  • Hearing Aids
  • Neurostimulation Devices
    • Spinal Cord Stimulation
    • Deep Brain Stimulation
    • Transcranial Magnetic Stimulation
  • Smart Inhalers
    • Asthma & COPD Management
    • Connected Inhalers with Data Tracking
  • Smart Drug Delivery Systems
    • Wearable Injectors
    • Implantable Drug Delivery Devices
  • Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
  • Pharmacies
  • Online Channel
  • Direct-to-Consumer (DTC)
  • Others (Hypermarkets, Specialty Retailers)
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals
  • Clinics
  • Home Care
  • Others (Sports, Fitness Centers, Assisted Living)
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Therapeutic Devices
    • 1.2.2. Device/Product
    • 1.2.3. Technology/Software
    • 1.2.4. Distribution
    • 1.2.5. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increase in personalized treatment plans
      • 3.2.1.2. Technological Advancements
      • 3.2.1.3. Rising Prevalence of Chronic Diseases
    • 3.2.2. Market Restraint Analysis
    • 3.2.3. Industry Opportunity Analysis
    • 3.2.4. Industry Challenge Analysis
    • 3.2.5. Case Studies
  • 3.3. Business Environment Analysis
    • 3.3.1. Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis
  • 3.4. COVID 19 Impact Analysis

Chapter 4. Smart Therapeutics Devices Market: Therapeutic Devices Type Estimates & Trend Analysis

  • 4.1. Therapeutic Devices Segment Dashboard
  • 4.2. Therapeutic Devices Market Share Movement Analysis, 2024 & 2030
  • 4.3. Market Size & Forecasts and Trend Analysis, by Devices Type, 2018 to 2030 (USD Million)
    • 4.3.1. Portable Oxygen Concentrators & Ventilators
      • 4.3.1.1. Portable Oxygen Concentrators & Ventilators market, 2018 - 2030 (USD Million)
    • 4.3.2. Insulin Pumps
      • 4.3.2.1. Insulin Pumps market, 2018 - 2030 (USD Million)
    • 4.3.3. Hearing Aids
      • 4.3.3.1. Hearing Aids market, 2018 - 2030 (USD Million)
    • 4.3.4. Neurostimulation Devices
      • 4.3.4.1. Neurostimulation Devices market, 2018 - 2030 (USD Million)
      • 4.3.4.2. Spinal Cord Stimulation
        • 4.3.4.2.1. Spinal Cord Stimulation market, 2018 - 2030 (USD Million)
      • 4.3.4.3. Deep Brain Stimulation
        • 4.3.4.3.1. Deep Brain Stimulation market, 2018 - 2030 (USD Million)
      • 4.3.4.4. Transcranial Magnetic Stimulation
        • 4.3.4.4.1. Transcranial Magnetic Stimulation market, 2018 - 2030 (USD Million)
    • 4.3.5. Smart Inhalers
      • 4.3.5.1. Smart Inhalers market, 2018 - 2030 (USD Million)
      • 4.3.5.2. Asthma & COPD Management
        • 4.3.5.2.1. Asthma & COPD Management market, 2018 - 2030 (USD Million)
      • 4.3.5.3. Connected Inhalers with Data Tracking
        • 4.3.5.3.1. Connected Inhalers with Data Tracking market, 2018 - 2030 (USD Million)
    • 4.3.6. Smart Drug Delivery Systems
      • 4.3.6.1. Smart Drug Delivery Systems market, 2018 - 2030 (USD Million)
      • 4.3.6.2. Wearable Injectors
        • 4.3.6.2.1. Wearable Injectors market, 2018 - 2030 (USD Million)
      • 4.3.6.3. Drug Delivery Devices
        • 4.3.6.3.1. Drug Delivery Devices market, 2018 - 2030 (USD Million)

Chapter 5. Smart Therapeutics Devices Market: Distribution Channel Estimates & Trend Analysis

  • 5.1. Distribution Segment Dashboard
  • 5.2. Distribution Market Share Movement Analysis, 2024 & 2030
  • 5.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
  • 5.4. Pharmacies
    • 5.4.1. Pharmacies market, 2018 - 2030 (USD Million)
  • 5.5. Online Channel
    • 5.5.1. Online Channel market, 2018 - 2030 (USD Million)
  • 5.6. Direct-to-Consumer (DTC)
    • 5.6.1. Direct-to-Consumer (DTC) market, 2018 - 2030 (USD Million)
  • 5.7. Others (Hypermarkets, Specialty Retailers)
    • 5.7.1. Others (Hypermarkets, Specialty Retailers) market, 2018 - 2030 (USD Million)

Chapter 6. Smart Therapeutics Devices Market: End Use Estimates & Trend Analysis

  • 6.1. End Use Segment Dashboard
  • 6.2. End Use Market Share Movement Analysis, 2024 & 2030
  • 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Hospitals market, 2018 - 2030 (USD Million)
  • 6.5. Clinics
    • 6.5.1. Clinics market, 2018 - 2030 (USD Million)
  • 6.6. Home Care
    • 6.6.1. Home Care market, 2018 - 2030 (USD Million)
  • 6.7. Others (Sports, Fitness Centers, Assisted Living)
    • 6.7.1. Others (Sports, Fitness Centers, Assisted Living) market, 2018 - 2030 (USD Million)

Chapter 7. Smart Therapeutics Devices Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Dashboard
  • 7.2. Regional Market: Key Takeaways
  • 7.3. North America
    • 7.3.1. North America smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key country dynamic
      • 7.3.2.2. Regulatory framework
      • 7.3.2.3. Competitive insights
      • 7.3.2.4. U.S. smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key country dynamic
      • 7.3.3.2. Regulatory framework
      • 7.3.3.3. Competitive insights
      • 7.3.3.4. Canada smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key country dynamic
      • 7.3.4.2. Regulatory framework
      • 7.3.4.3. Competitive insights
      • 7.3.4.4. Mexico smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamic
      • 7.4.2.2. Regulatory framework
      • 7.4.2.3. Competitive insights
      • 7.4.2.4. Germany smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. UK
      • 7.4.3.1. Key country dynamic
      • 7.4.3.2. Regulatory framework
      • 7.4.3.3. Competitive insights
      • 7.4.3.4. UK smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key country dynamic
      • 7.4.4.2. Regulatory framework
      • 7.4.4.3. Competitive insights
      • 7.4.4.4. France smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key country dynamic
      • 7.4.5.2. Regulatory framework
      • 7.4.5.3. Competitive insights
      • 7.4.5.4. Italy smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key country dynamic
      • 7.4.6.2. Regulatory framework
      • 7.4.6.3. Competitive insights
      • 7.4.6.4. Spain smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Denmark
      • 7.4.7.1. Key country dynamic
      • 7.4.7.2. Regulatory framework
      • 7.4.7.3. Competitive insights
      • 7.4.7.4. Denmark smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key country dynamic
      • 7.4.8.2. Regulatory framework
      • 7.4.8.3. Competitive insights
      • 7.4.8.4. Sweden smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key country dynamic
      • 7.4.9.2. Regulatory framework
      • 7.4.9.3. Competitive insights
      • 7.4.9.4. Norway smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key country dynamic
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive insights
      • 7.5.2.4. Japan smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key country dynamic
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive insights
      • 7.5.3.4. China smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key country dynamic
      • 7.5.4.2. Regulatory framework
      • 7.5.4.3. Competitive insights
      • 7.5.4.4. India smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamic
      • 7.5.5.2. Regulatory framework
      • 7.5.5.3. Competitive insights
      • 7.5.5.4. South Korea smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Australia
      • 7.5.6.1. Key country dynamic
      • 7.5.6.2. Regulatory framework
      • 7.5.6.3. Competitive insights
      • 7.5.6.4. Australia smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Thailand
      • 7.5.7.1. Key country dynamic
      • 7.5.7.2. Regulatory framework
      • 7.5.7.3. Competitive insights
      • 7.5.7.4. Thailand smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America smart therapeutics devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key country dynamic
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive insights
      • 7.6.2.4. Brazil smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key country dynamic
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Competitive insights
      • 7.6.3.4. Argentina smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. MEA smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key country dynamic
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive insights
      • 7.7.2.4. South Africa smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key country dynamic
      • 7.7.3.2. Regulatory framework
      • 7.7.3.3. Competitive insights
      • 7.7.3.4. Saudi smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key country dynamic
      • 7.7.4.2. Regulatory framework
      • 7.7.4.3. Competitive insights
      • 7.7.4.4. UAE smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key country dynamic
      • 7.7.5.2. Regulatory framework
      • 7.7.5.3. Competitive insights
      • 7.7.5.4. Kuwait smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Inogen, Inc.
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial performance
      • 8.5.1.3. Product benchmarking
      • 8.5.1.4. Strategic initiatives
    • 8.5.2. Presspart Verwaltungs GmbH.
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial performance
      • 8.5.2.3. Product benchmarking
      • 8.5.2.4. Strategic initiatives
    • 8.5.3. Cognita Labs
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial performance
      • 8.5.3.3. Product benchmarking
      • 8.5.3.4. Strategic initiatives
    • 8.5.4. adherium
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial performance
      • 8.5.4.3. Product benchmarking
      • 8.5.4.4. Strategic initiatives
    • 8.5.5. Medtronic
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial performance
      • 8.5.5.3. Product benchmarking
      • 8.5.5.4. Strategic initiatives
    • 8.5.6. Hoffmann-La Roche AG
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial performance
      • 8.5.6.3. Product benchmarking
      • 8.5.6.4. Strategic initiatives
    • 8.5.7. Insulet Corporation
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial performance
      • 8.5.7.3. Product benchmarking
      • 8.5.7.4. Strategic initiatives
    • 8.5.8. Audicus
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial performance
      • 8.5.8.3. Product benchmarking
      • 8.5.8.4. Strategic initiatives
    • 8.5.9. Eargo, Inc.
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial performance
      • 8.5.9.3. Products & Services benchmarking
      • 8.5.9.4. Strategic initiatives
    • 8.5.10. Nidek Medical Products, Inc.
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial performance
      • 8.5.10.3. Product benchmarking
      • 8.5.10.4. Strategic initiatives
    • 8.5.11. Koninklijke Philips N.V.
      • 8.5.11.1. Overview
      • 8.5.11.2. Financial performance
      • 8.5.11.3. Product benchmarking
      • 8.5.11.4. Strategic initiatives
    • 8.5.12. Drive Devilbiss International
      • 8.5.12.1. Overview
      • 8.5.12.2. Financial performance
      • 8.5.12.3. Product benchmarking
      • 8.5.12.4. Strategic initiatives
    • 8.5.13. Tandem Diabetes Care, Inc.
      • 8.5.13.1. Overview
      • 8.5.13.2. Financial performance
      • 8.5.13.3. Product benchmarking
      • 8.5.13.4. Strategic initiatives
    • 8.5.14. Ypsomed
      • 8.5.14.1. Overview
      • 8.5.14.2. Financial performance
      • 8.5.14.3. Product benchmarking
      • 8.5.14.4. Strategic initiatives
    • 8.5.15. GN Hearing
      • 8.5.15.1. Overview
      • 8.5.15.2. Financial performance
      • 8.5.15.3. Product benchmarking
      • 8.5.15.4. Strategic initiatives
    • 8.5.16. Cochlear Ltd.
      • 8.5.16.1. Overview
      • 8.5.16.2. Financial performance
      • 8.5.16.3. Product benchmarking
      • 8.5.16.4. Strategic initiatives
    • 8.5.17. Sonova.
      • 8.5.17.1. Overview
      • 8.5.17.2. Financial performance
      • 8.5.17.3. Product benchmarking
      • 8.5.17.4. Strategic initiatives
    • 8.5.18. Boston Scientific Corporation
      • 8.5.18.1. Overview
      • 8.5.18.2. Financial performance
      • 8.5.18.3. Product benchmarking
      • 8.5.18.4. Strategic initiatives
    • 8.5.19. Abbott.
      • 8.5.19.1. Overview
      • 8.5.19.2. Financial performance
      • 8.5.19.3. Product benchmarking
      • 8.5.19.4. Strategic initiatives
    • 8.5.20. Nevro Corp.
      • 8.5.20.1. Overview
      • 8.5.20.2. Financial performance
      • 8.5.20.3. Product benchmarking
      • 8.5.20.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 North America smart therapeutic devices market, by country, 2018 - 2030 (USD Million)
  • Table 4 North America smart therapeutic devices market, devices types, 2018 - 2030 (USD Million)
  • Table 5 North America smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 6 North America smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
  • Table 7 U.S. smart therapeutic devices market, devices types, 2018 - 2030 (USD Million)
  • Table 8 U.S. smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 9 U.S. smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
  • Table 10 Canada smart therapeutic devices market, devices types, 2018 - 2030 (USD Million)
  • Table 11 Canada smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 12 Canada smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Mexico smart therapeutic devices market, devices types, 2018 - 2030 (USD Million)
  • Table 14 Mexico smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 15 Mexico smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Europe smart therapeutic devices market, by devices types, 2018 - 2030 (USD Million)
  • Table 17 Europe smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 18 Europe smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
  • Table 19 UK smart therapeutic devices market, by devices types, 2018 - 2030 (USD Million)
  • Table 20 UK smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 21 UK smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
  • Table 22 Germany smart therapeutic devices market, by devices types, 2018 - 2030 (USD Million)
  • Table 23 Germany smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 24 Germany smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
  • Table 25 France smart therapeutic devices market, by devices types, 2018 - 2030 (USD Million)
  • Table 26 France smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 27 France smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Italy smart therapeutic devices market, by devices types, 2018 - 2030 (USD Million)
  • Table 29 Italy smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 30 Italy smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
  • Table 31 Spain smart therapeutic devices market, by devices types, 2018 - 2030 (USD Million)
  • Table 32 Spain smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 33 Spain smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
  • Table 34 Norway smart therapeutic devices market, by devices types, 2018 - 2030 (USD Million)
  • Table 35 Norway smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 36 Norway smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Sweden smart therapeutic devices market, by devices types, 2018 - 2030 (USD Million)
  • Table 38 Sweden smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 39 Sweden smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Denmark smart therapeutic devices market, by devices types, 2018 - 2030 (USD Million)
  • Table 41 Denmark smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 42 Denmark smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific smart therapeutic devices market, by country, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific smart therapeutic devices market, by devices types, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Japan smart therapeutic devices market, by devices types, 2018 - 2030 (USD Million)
  • Table 48 Japan smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 49 Japan smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
  • Table 50 China smart therapeutic devices market, by devices types, 2018 - 2030 (USD Million)
  • Table 51 China smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 52 China smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
  • Table 53 India smart therapeutic devices market, by devices types, 2018 - 2030 (USD Million)
  • Table 54 India smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 55 India smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
  • Table 56 Australia smart therapeutic devices market, by devices types, 2018 - 2030 (USD Million)
  • Table 57 Australia smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 58 Australia smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
  • Table 59 South Korea smart therapeutic devices market, by devices types, 2018 - 2030 (USD Million)
  • Table 60 South Korea smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 61 South Korea smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
  • Table 62 Thailand smart therapeutic devices market, devices types, 2018 - 2030 (USD Million)
  • Table 63 Thailand smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 64 Thailand smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
  • Table 65 Latin America smart therapeutic devices market, by country, 2018 - 2030 (USD Million)
  • Table 66 Latin America smart therapeutic devices market, devices types, 2018 - 2030 (USD Million)
  • Table 67 Latin America smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 68 Latin America smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Brazil smart therapeutic devices market, devices types, 2018 - 2030 (USD Million)
  • Table 70 Brazil smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 71 Brazil smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
  • Table 72 Argentina smart therapeutic devices market, devices types, 2018 - 2030 (USD Million)
  • Table 73 Argentina smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 74 Argentina smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
  • Table 75 Middle East & Africa smart therapeutic devices market, by country, 2018 - 2030 (USD Million)
  • Table 76 Middle East & Africa smart therapeutic devices market, devices types, 2018 - 2030 (USD Million)
  • Table 77 Middle East & Africa smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 78 Middle East & Africa smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
  • Table 79 South Africa smart therapeutic devices market, devices types, 2018 - 2030 (USD Million)
  • Table 80 South Africa smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 81 South Africa smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia smart therapeutic devices market, devices types, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
  • Table 85 UAE smart therapeutic devices market, devices types , 2018 - 2030 (USD Million)
  • Table 86 UAE smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 87 UAE smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
  • Table 88 Kuwait smart therapeutic devices market, devices types, 2018 - 2030 (USD Million)
  • Table 89 Kuwait smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 90 Kuwait smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Smart therapeutics devices market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market formulation & validation
  • Fig. 6 Market research approaches
  • Fig. 7 Value-chain-based sizing & forecasting
  • Fig. 8 QFD modelling for market share assessment
  • Fig. 9 Commodity flow analysis
  • Fig. 10 Market snapshot
  • Fig. 11 Market segmentation (USD Million
  • Fig. 12 Competitive landscape
  • Fig. 13 Parent market outlook (In USD Billion)
  • Fig. 14 Related/ancillary market outlook (In USD Billion)
  • Fig. 15 Smart therapeutics devices market dynamics
  • Fig. 16 Smart therapeutics devices market: Porter's five forces analysis
  • Fig. 17 Smart therapeutics devices market: PESTLE analysis
  • Fig. 18 Smart therapeutics devices market: Devices Type segment dashboard
  • Fig. 19 Smart therapeutics devices market: Devices Type market share analysis, 2024 & 2030
  • Fig. 20 Portable Oxygen Concentrators & Ventilators market, 2018 - 2030 (USD Million)
  • Fig. 21 Insulin Pumps market, 2018 - 2030 (USD Million)
  • Fig. 22 Hearing Aids market, 2018 - 2030 (USD Million)
  • Fig. 23 Neurostimulation Devices market, 2018 - 2030 (USD Million)
  • Fig. 24 Spinal Cord Stimulation market, 2018 - 2030 (USD Million)
  • Fig. 25 Deep Brain Stimulation market, 2018 - 2030 (USD Million)
  • Fig. 26 Transcranial Magnetic Stimulation market, 2018 - 2030 (USD Million)
  • Fig. 27 Smart Inhalers market, 2018 - 2030 (USD Million)
  • Fig. 28 Asthma & COPD Management market, 2018 - 2030 (USD Million)
  • Fig. 29 Connected Inhalers with Data Tracking market, 2018 - 2030 (USD Million)
  • Fig. 30 Smart Drug Delivery Systems market, 2018 - 2030 (USD Million)
  • Fig. 31 Wearable Injectors market, 2018 - 2030 (USD Million)
  • Fig. 32 Drug Delivery Devices market, 2018 - 2030 (USD Million)
  • Fig. 33 Smart therapeutic devices market: Distribution market share analysis, 2024 & 2030
  • Fig. 34 Pharmacies market, 2018 - 2030 (USD Million)
  • Fig. 35 Online Channel market, 2018 - 2030 (USD Million
  • Fig. 36 Direct-to-Consumer (DTC) market, 2018 - 2030 (USD Million
  • Fig. 37 Others (Hypermarkets, Specialty Retailers) market, 2018 - 2030 (USD Million
  • Fig. 38 Smart therapeutic devices market: End use market share analysis, 2024 & 2030
  • Fig. 39 Hospitals market, 2018 - 2030 (USD Million)
  • Fig. 40 Clinics market, 2018 - 2030 (USD Million)
  • Fig. 41 Home Care market, 2018 - 2030 (USD Million)
  • Fig. 42 Others (Sports, Fitness Centers, Assisted Living) market, 2018 - 2030 (USD Million)
  • Fig. 43 Smart therapeutic devices market revenue, by region
  • Fig. 44 Regional marketplace: Key takeaways
  • Fig. 45 North America smart therapeutic devices market, 2018 - 2030 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 US smart therapeutic devices market, 2018 - 2030 (USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 Canada smart therapeutic devices market, 2018 - 2030 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 Mexico smart therapeutic devices market, 2018 - 2030 (USD Million)
  • Fig. 52 Europe smart therapeutic devices market, 2018 - 2030 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 UK smart therapeutic devices market, 2018 - 2030 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 Germany smart therapeutic devices market, 2018 - 2030 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 France smart therapeutic devices market, 2018 - 2030 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 Italy smart therapeutic devices market, 2018 - 2030 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Spain smart therapeutic devices market, 2018 - 2030 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Norway smart therapeutic devices market, 2018 - 2030 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Sweden smart therapeutic devices market, 2018 - 2030 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Denmark smart therapeutic devices market, 2018 - 2030 (USD Million)
  • Fig. 69 Asia Pacific smart therapeutic devices market, 2018 - 2030 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Japan smart therapeutic devices market, 2018 - 2030 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 China smart therapeutic devices market, 2018 - 2030 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 India smart therapeutic devices market, 2018 - 2030 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 Australia smart therapeutic devices market, 2018 - 2030 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 South Korea smart therapeutic devices market, 2018 - 2030 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 Thailand smart therapeutic devices market, 2018 - 2030 (USD Million)
  • Fig. 82 Latin America smart therapeutic devices market, 2018 - 2030 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 Brazil smart therapeutic devices market, 2018 - 2030 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Argentina smart therapeutic devices market, 2018 - 2030 (USD Million)
  • Fig. 87 MEA smart therapeutic devices market, 2018 - 2030 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 South Africa smart therapeutic devices market, 2018 - 2030 (USD Million)
  • Fig. 90 Key country dynamics
  • Fig. 91 Saudi Arabia smart therapeutic devices market, 2018 - 2030 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 UAE smart therapeutic devices market, 2018 - 2030 (USD Million)
  • Fig. 94 Key country dynamics
  • Fig. 95 Kuwait healthcare information system market, 2018 - 2030 (USD Million)
  • Fig. 96 Company categorization
  • Fig. 97 Company market position analysis
  • Fig. 98 Strategic framework